Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference
September 09 2020 - 08:00AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s
healthcare company, today announced that Al Altomari, Chairman and
Chief Executive Officer, will participate in a fireside chat at the
H.C. Wainwright 22nd Annual Global Investment Virtual Conference on
Wednesday, September 16, 2020 at 11:30 a.m. EDT.
A live webcast of the fireside chat will be
available in the Events and Presentations section of the Investor
Relations page or by clicking here. The
archived webcast will be available on the Company's website for 30
days.
About Agile Therapeutics,
Inc.Agile Therapeutics is a women's healthcare
company dedicated to fulfilling the unmet health needs of today’s
women. Our product candidates are designed to provide women
with contraceptive options that offer freedom from taking a daily
pill, without committing to a longer-acting method. Our
initial product, Twirla®, (levonorgestrel and ethinyl estradiol)
transdermal system is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The
Company may occasionally disseminate material, nonpublic
information on the Company’s website.
Follow Agile on LinkedIn and
Twitter: @AgileTher.
Contact: Matt RileyHead
of Investor Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2023 to Mar 2024